Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Philip Morris
PM
|
$8.88B |
| 2 |
Gilead Sciences
GILD
|
$8.02B |
| 3 |
Microsoft
MSFT
|
$7.4B |
| 4 |
Amgen
AMGN
|
$6.62B |
| 5 |
Altria Group
MO
|
$5.28B |
Top Sells
Sector Composition
| 1 | Healthcare | 18.95% |
| 2 | Technology | 12.52% |
| 3 | Communication Services | 11.55% |
| 4 | Industrials | 10.7% |
| 5 | Consumer Staples | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Philip Morris
PM
$260B
| $8.88B | 3.78% | +102,547,012 | New | +$8.88B |
|
|
2
Gilead Sciences
GILD
$140B
| $8.02B | 3.41% | +156,668,826 | New | +$8.02B |
|
|
3
Microsoft
MSFT
$3.77T
| $7.4B | 3.14% | +214,204,028 | New | +$7.4B |
|
|
4
Amgen
AMGN
$155B
| $6.62B | 2.81% | +67,059,503 | New | +$6.62B |
|
|
5
Altria Group
MO
$113B
| $5.28B | 2.24% | +150,888,600 | New | +$5.28B |
|
6
Verizon
VZ
$186B
| $4.91B | 2.09% | +97,613,203 | New | +$4.91B |
|
7
Alphabet (Google) Class C
GOOG
$2.58T
| $4.88B | 2.07% | +5,540,839 | New | +$4.88B |
|
8
AbbVie
ABBV
$372B
| $4.45B | 1.89% | +107,610,838 | New | +$4.45B |
|
9
Amazon
AMZN
$2.44T
| $4.01B | 1.71% | +14,448,800 | New | +$4.01B |
|
10
Oracle
ORCL
$635B
| $3.85B | 1.63% | +125,188,800 | New | +$3.85B |
|
11
Home Depot
HD
$405B
| $3.63B | 1.54% | +46,831,498 | New | +$3.63B |
|
12
AT&T
T
$209B
| $3.06B | 1.3% | +86,342,230 | New | +$3.06B |
|
13
Texas Instruments
TXN
$184B
| $2.94B | 1.25% | +84,401,311 | New | +$2.94B |
|
14
EOG Resources
EOG
$68.2B
| $2.78B | 1.18% | +21,085,353 | New | +$2.78B |
|
15
DuPont de Nemours
DD
$32.2B
| $2.73B | 1.16% | +84,908,663 | New | +$2.73B |
|
16
Schlumberger
SLB
$55B
| $2.66B | 1.13% | +37,164,339 | New | +$2.66B |
|
17
General Dynamics
GD
$87.3B
| $2.61B | 1.11% | +33,358,700 | New | +$2.61B |
|
18
Lumen
LUMN
$5.1B
| $2.59B | 1.1% | +73,265,235 | New | +$2.59B |
|
19
General Motors
GM
$55.8B
| $2.44B | 1.04% | +73,384,250 | New | +$2.44B |
|
20
Union Pacific
UNP
$133B
| $2.35B | 1% | +15,250,127 | New | +$2.35B |
|
21
CSX Corp
CSX
$60.6B
| $2.35B | 1% | +101,212,836 | New | +$2.35B |
|
22
Teva Pharmaceuticals
TEVA
$21.1B
| $2.28B | 0.97% | +58,182,900 | New | +$2.28B |
|
23
UnitedHealth
UNH
$281B
| $2.24B | 0.95% | +34,221,187 | New | +$2.24B |
|
24
Comcast
CMCSA
$125B
| $2.24B | 0.95% | +53,446,038 | New | +$2.24B |
|
|
ALXN
25
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.98B | 0.84% | +21,428,100 | New | +$1.98B |
|